ClinicalTrials.Veeva

Menu

Clinical Trial Recruitment and Retention Strategies for Family Members in the ICU (SWAT)

L

Lady Davis Institute

Status

Enrolling

Conditions

Family Members
Study Enrollment
Compensation Incentives
Recruitment of Participants
Recruitment
Retention
Clinical Study
Retention of Participants

Treatments

Other: Compensation
Other: Written informed consent with infographic

Study type

Interventional

Funder types

Other

Identifiers

NCT06588101
2024-4023

Details and patient eligibility

About

There is a need to identify strategies that improve the conduct of clinical trials involving family members of intensive care unit (ICU) patients. The purpose of the present study is to evaluate recruitment and retention strategies for clinical trials involving family members of ICU patients. 4 strategies (2 recruitment and 2 retention) will be tested. Investigators will integrate the strategies into three existing studies that involve family members of ICU patients. Participants will be randomized using a 2x2 factorial design. The co-primary outcomes are recruitment percentage (participants enrolled/participants approached) and retention percentage (participants completing follow-up/participants enrolled).

Full description

Family engagement in the ICU is recommended by critical care professional societies, but insufficient evidence of its benefits for patients and family members has hindered clinical uptake. Thus, high-quality evidence is needed to promote and support family engagement practices. A specific unmet need is to identify strategies to improve the recruitment and retention of families in clinical trials in the ICU setting. The objective of this study is to evaluate recruitment and retention strategies for clinical trials involving family members in the ICU setting.

Methodological Approach: Investigators will use a Study Within a Trial (SWAT) design to embed a factorial randomized trial of 160 participants enrolled across investigator group's three ongoing studies involving family members of ICU patients: FAME, VR-Family, and NGAGE. Investigators expect 160 participants to be enrolled over a 6-month period. Participants will be randomized by 2x2 factorial design to selected recruitment and/or retention strategies. The co-primary outcomes will be (1) recruitment rate and (2) retention rate.

Enrollment

160 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Has family member admitted to an intensive care unit.
  • Expected hospital stay > 48 hours
  • Able to participate in English or French

Exclusion criteria

  • Has another family member participating in the trial
  • Repeat admissions within the study period

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Factorial Assignment

Masking

Double Blind

160 participants in 4 patient groups

Both recruitment strategies
Experimental group
Description:
Consent form with Infographic + Large compensation
Treatment:
Other: Written informed consent with infographic
Other: Compensation
Neither recruitment strategy
No Intervention group
Description:
Consent form + No compensation
One recruitment strategy - Infographic
Experimental group
Description:
Consent form with Infographic + No compensation
Treatment:
Other: Written informed consent with infographic
One recruitment strategy - Compensation
Experimental group
Description:
Consent form + Large compensation
Treatment:
Other: Compensation

Trial contacts and locations

1

Loading...

Central trial contact

Jillian Kifell, MSc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems